1 filter applied. Clear filter
Op-Ed
Reforms Needed to Modernize the US Food and Drug Administration’s Oversight of Dietary Supplements, Cosmetics, and Diagnostic Tests
Scott Gottlieb, MD and Mark B. McClellan, MD, PhD
2022
Read MoreOp-Ed
America needs a confirmed leader at FDA — now
Mark McClellan, Scott Gottlieb, and Margaret Hamburg and Andy Slavitt
2022
Read MorePolicy Brief
Enhancing the Accessibility and Utility of Drug Interaction Information in Prescription Drug Labeling
Nicholas R. Harrison, Sarah M. Sheehan, Mongthuong T. Tran, Jeanne Herndon, Eric
Brodsky, and Joseph A. Grillo
2021
Read MoreLetter
FDA Commissioners Letter of Support for Rob Califf
Andrew von Eschenbach, MD, Scott Gottlieb, MD, Stephen Hahn, MD, Margaret Hamburg, MD, Jane Henney, MD, Mark McClellan, MD PhD
2021
Read More